Long-term outcome and natural history of uterine adenosarcomas

Gynecologic Oncology

Volumn 119, Issue 2, 2010, Pages 305-308

  Arend, Rebecca ^a   Bagaria, Madhu ^a   Lewin, Sharyn N ^a,b   Sun, Xuming ^a   Deutsch, Israel ^a,b   Burke, William M ^a   Herzog, Thomas J ^a,b   Wright, Jason D ^a,b  

^a Columbia University ^*  (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

Adenosarcoma; Carcinosarcoma; Endometrial cancer; Uterine cancer; Uterine sarcoma

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DATA BASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; UTERUS CARCINOMA; UTERUS SARCOMA; ADENOSARCOMA; AGE; CARCINOSARCOMA; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE; UNITED STATES; UTERINE NEOPLASMS;

ADENOSARCOMA; ADULT; AGE FACTORS; CARCINOSARCOMA; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; UNITED STATES; UTERINE NEOPLASMS;

EID: 77957755222     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.07.001     Document Type: Article

References (22)

1. P.B. Clement, and R.E. Scully Mullerian adenosarcoma of the uterus. A clinicopathologic analysis of ten cases of a distinctive type of mullerian mixed tumor Cancer 34 1974 1138 1149
2. P.B. Clement, and R.E. Scully Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature Hum Pathol 21 1990 363 381
3. T. Kaku, S.G. Silverberg, F.J. Major, A. Miller, B. Fetter, and M.F. Brady Adenosarcoma of the uterus: a Gynecologic Oncology Group clinicopathologic study of 31 cases Int J Gynecol Pathol 11 1992 75 88
4. S.E. Brooks, M. Zhan, T. Cote, and C.R. Baquet Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999 Gynecol Oncol 93 2004 204 208
5. C.J. Zaloudek, and H.J. Norris Adenofibroma and adenosarcoma of the uterus: a clinicopathologic study of 35 cases Cancer 48 1981 354 366
6. Surveillance, Epidemiology, and End Results, SEER*Stat Database: Incidence-SEER 9 Regs Limited-Use, Nov 2006 Sub (1973-2004), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission. http://.seer.cancer. gov. Accessed October, 2007.
7. The Surveillance, Epidemiology, and End Results (SEER) Program, Data Quality 2007 National Cancer Institute (http://seer.cancer.gov/about/. Accessed October, 2007)
8. C.M. Frey, M.M. McMillen, C.D. Cowan, J.W. Horm, and L.G. Kessler Representativeness of the surveillance, epidemiology, and end results program data: recent trends in cancer mortality rates J Natl Cancer Inst 84 1992 872 877
9. T.R. Baker, M.S. Piver, S.B. Lele, and Y. Tsukada Stage I uterine adenosarcoma: a report of six cases J Surg Oncol 37 1988 128 132
10. J. Hariri Mullerian adenosarcoma of the endometrium: review of the literature and report of two cases Int J Gynecol Pathol 2 1983 182 191
11. P.B. Clement Mullerian adenosarcomas of the uterus with sarcomatous overgrowth. A clinicopathological analysis of 10 cases Am J Surg Pathol 13 1989 28 38
12. M. Hallak, J.F. Peipert, P.B. Heller, T.V. Sedlacek, and G.M. Schauer Mullerian adenosarcoma of the uterus with sarcomatous overgrowth J Surg Oncol 51 1992 68 70
13. T.C. Krivak, J.D. Seidman, J.W. McBroom, P.J. MacKoul, L.M. Aye, and G.S. Rose Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival Gynecol Oncol 83 2001 89 94
14. N. Bansal, T.J. Herzog, and V.E. Seshan Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior Obstet Gynecol 112 2008 64 70
15. J.D. Wright, J. Fiorelli, and P.B. Schiff Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time Cancer 115 2009 1276 1285
16. J.D. Wright, V.E. Seshan, and M. Shah The role of radiation in improving survival for early-stage carcinosarcoma and leiomyosarcoma Am J Obstet Gynecol 199 2008 536e1-536e8
17. J.D. Seidman, and S. Chauhan Evaluation of the relationship between adenosarcoma and carcinosarcoma and a hypothesis of the histogenesis of uterine sarcomas Int J Gynecol Pathol 22 2003 75 82
18. F.J. Major, J.A. Blessing, and S.G. Silverberg Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study Cancer 71 1993 1702 1709
19. D.S. Kapp, J.Y. Shin, and J.K. Chan Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy Cancer 112 2008 820 830
20. S.G. Silverberg, F.J. Major, and J.A. Blessing Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases Int J Gynecol Pathol 9 1990 1 19
21. F. Guidozzi, T. Smith, A.B. Koller, and L. Reinecke Management of uterine Mullerian adenosarcoma with extrauterine metastatic deposits Gynecol Oncol 77 2000 464 466
22. Y. Shi, Z. Liu, Z. Peng, H. Liu, K. Yang, and X. Yao The diagnosis and treatment of Mullerian adenosarcoma of the uterus Aust NZ J Obstet Gynaecol 48 2008 596 600